Biocon urges government to exempt cancer, rare-disease drugs from tax in Budget 2025

Kiran Mazumdar-Shaw , Chairperson of major drugmaker Biocon Ltd., urged the government to eliminate tax on drugs for cancer treatment and for chronic and rare diseases, ahead of the budget 2025 announcement, expected next month.
Read more...